Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:THOR

Synthorx (THOR) Stock Price, News & Analysis

Synthorx logo

About Synthorx Stock (NASDAQ:THOR)

Advanced Chart

Key Stats

Today's Range
$67.99
$67.99
50-Day Range
$67.99
$67.99
52-Week Range
$11.05
$71.90
Volume
N/A
Average Volume
474,507 shs
Market Capitalization
$2.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive THOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Synthorx and its competitors with MarketBeat's FREE daily newsletter.

THOR Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tied to President Trump's Executive Order #14196 could not only rescue Social Security... But also boost benefits by up to 400%, according to legendary investor Louis Navellier.
Biosimilar Interleukins Global Market Report 2023
See More Headlines

THOR Stock Analysis - Frequently Asked Questions

Synthorx, Inc. (NASDAQ:THOR) posted its earnings results on Tuesday, November, 5th. The medical instruments supplier reported ($0.38) earnings per share for the quarter, topping analysts' consensus estimates of ($0.50) by $0.12.

Synthorx (THOR) raised $100 million in an initial public offering (IPO) on Friday, December 7th 2018. The company issued 9,100,000 shares at $10.00-$12.00 per share. Jefferies, Leerink Partners and Evercore ISI served as the underwriters for the IPO and H.C. Wainwright & Co. was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Synthorx investors own include Pfizer (PFE), NVIDIA (NVDA), Gilead Sciences (GILD), Meta Platforms (META), Alibaba Group (BABA), Tesla (TSLA) and Salesforce (CRM).

Company Calendar

Last Earnings
11/05/2019
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:THOR
CIK
350907
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($6.59)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$56.61 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-26.09%
Return on Assets
-24.62%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
18.87
Quick Ratio
18.87

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.72 per share
Price / Book
10.12

Miscellaneous

Outstanding Shares
32,338,000
Free Float
N/A
Market Cap
$2.20 billion
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:THOR) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners